Skip to main content
Health Innovation Hub (H2i) @ U of T logo
Contact Subscribe
About
Ventures
Opportunities
News
Events
Join
news

Interface Biologics Inc.’s surface modification technology is being acquired by Evonik

Interface Biologics Inc.’s surface modification technology is being acquired by Evonik
Date
September 5, 2019
Share this page
  • LinkedIn
  • Facebook
  • Twitter
  • Mail
By
officebureau
Newsletter

University of Toronto
  • Accessibility
  • Privacy

© 2021 Health Innovation Hub | Temerty Faculty of Medicine | University of Toronto